A Decades Old Cancer Vaccine Suggests A Strategy For Improving Today’s Cancer Therapy

Vidcast: https://www.instagram.com/p/DcWqiJwuoyQ/ More than two decades ago, women with advanced HER2-positive breast cancer received an experimental vaccine. Researchers later found that the patients who survived more than 18 years still had immune cells capable of recognizing their cancer. Their long-lasting capable killer cells all bore CD27, a marker associated with long-lasting immune memory.…